AstraZeneca Deepens China Bet With New Asthma and Cancer Drug Deals

‼️ AstraZeneca has teamed with Chinese innovators on a range of medicines. It recently licensed an inhaled drug for asthma and chronic obstructive pulmonary disease that’s code-named TQC3721, from Sino BioPharmaceutical , as well as the oral targeted cancer drug Zegfrovy from Dizal Pharmaceutical . It is developing oral cancer drug Orpathys, with Hutchmed .

Strait of Hormuz Tensions Escalate as Iran Downs U.S. Drone, Oil Talks Stall

‼️ Iran said it destroyed an advanced U.S. drone over the Strait of Hormuz, while President Trump suggested Washington could take control of Iranian oil under an arrangement similar to its earlier Venezuela deal. Talks in Oman between Iran and Gulf states on potential agreements governing the critical oil-and-gas shipping route have meanwhile been postponed.